{"denoms":[{"counts":[{"groupId":"BG000","value":"240"},{"groupId":"BG001","value":"121"},{"groupId":"BG002","value":"361"}],"units":"Participants"}],"groups":[{"description":"Nivolumab was provided at a dose of 3 milligrams/kilogram (mg/kg) using an intravenous (IV) solution for Injection every 2 weeks until disease progression.","id":"BG000","title":"Nivolumab 3mg/kg"},{"description":"Participants were provided a dose of Cetuximab intravenous (IV) solution for injection at a dose of 400 milligrams per square meter (mg/m\\^2) for the first dose followed that a doses of 250 mg/m\\^2 weekly until disease progression OR a Methotrexate intravenous (IV) solution for Injection at a dose of 40 or 60 mg/m\\^2 weekly until disease progression OR a Docetaxel intravenous (IV) solution for Injection at a dose of 30 or 40 mg/m\\^2 weekly until disease progression. The decision regarding which treatment the participant received was at the discretion of the investigator and referred to as Investigators Choice","id":"BG001","title":"Investigators Choice"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.15","value":"59.0"},{"groupId":"BG001","spread":"11.00","value":"59.4"},{"groupId":"BG002","spread":"10.43","value":"59.1"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"172"},{"groupId":"BG001","value":"76"},{"groupId":"BG002","value":"248"}]}],"title":"< 65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"56"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"95"}]}],"title":">=65 and <75 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"18"}]}],"title":">=75 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"61"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"197"},{"groupId":"BG001","value":"103"},{"groupId":"BG002","value":"300"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"196"},{"groupId":"BG001","value":"104"},{"groupId":"BG002","value":"300"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"13"}]}],"title":"Black or African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"43"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"5"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"13"}]}],"title":"Hispanic/Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"132"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"192"}]}],"title":"Not Hispanic/Latino"},{"categories":[{"measurements":[{"groupId":"BG000","value":"99"},{"groupId":"BG001","value":"57"},{"groupId":"BG002","value":"156"}]}],"title":"Not Reported"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}]}